Abilify and Rizatriptan benzoate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Abilify (aripiprazole) and Rizatriptan benzoate (rizatriptan benzoate). Common drug interactions include pain among females.

The phase IV clinical study analyzes what interactions people have when they take Abilify and Rizatriptan benzoate. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,454 Abilify users. Check the latest studies of Abilify.

What is Rizatriptan benzoate?

Rizatriptan benzoate has active ingredients of rizatriptan benzoate. It is often used in migraine. eHealthMe is studying from 1,886 Rizatriptan benzoate users. Check the latest studies of Rizatriptan benzoate.

On Jul, 08, 2026

17 people who take Abilify and Rizatriptan benzoate together, and have interactions are studied.

Abilify and Rizatriptan benzoate drug interactions.

What are the common drug interactions of Abilify and Rizatriptan Benzoate, by gender? *:

female:

Pain
Headache (pain in head)
Anxiety
Grip strength decreased
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Osteonecrosis (death of bone)
Ascites (accumulation of fluid in the abdominal cavity)
Blood pressure increased
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Diverticulum intestinal (a pouch that is attached to the first part of the small intestine)

male:

n/a

What are the common drug interactions of Abilify and Rizatriptan Benzoate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Infection

40-49:

Pain
Headache (pain in head)
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Osteonecrosis (death of bone)
Blood pressure increased
Fatigue (feeling of tiredness)
Hip arthroplasty
Hypoaesthesia (reduced sense of touch or sensation)
Injection site reaction
Lethargy (tiredness)

50-59:

n/a

60+:

Fall
Head injury
Small intestinal obstruction (blockage in small intestine)
Injection site pain
Localised infection (infection at the single location)
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
Ascites (accumulation of fluid in the abdominal cavity)
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Diverticulum intestinal (a pouch that is attached to the first part of the small intestine)
Intestinal obstruction

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 29.41%
Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 4 people, 23.53%
Infection: 3 people, 17.65%
Drowsiness: 3 people, 17.65%
High Blood Pressure: 3 people, 17.65%
Type 2 Diabetes: 2 people, 11.76%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 11.76%
High Blood Cholesterol: 2 people, 11.76%
Asthma: 2 people, 11.76%
Stable Angina (a constant chest pain): 2 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and Rizatriptan benzoate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously